Global STD Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by STD Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global STD Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Chlamydia Testing
  • 1.4.3 Syphilis Testing
  • 1.4.4 Gonorrhea Testing
  • 1.4.5 Herpes Simplex Virus Testing
  • 1.4.6 Human Papilloma Virus Testing
  • 1.4.7 Human Immunodeficiency Virus Testing
  • 1.4.8 Chancroid Testing
• 1.5 Market by Application
  • 1.5.1 Global STD Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Laboratory Testing
  • 1.5.3 Point of Care Testing
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global STD Diagnostics Market Perspective (2015-2026)
• 2.2 Global STD Diagnostics Growth Trends by Regions
  • 2.2.1 STD Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 STD Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 STD Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 STD Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key STD Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top STD Diagnostics Players by Market Size
  • 3.1.1 Global Top STD Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global STD Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global STD Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global STD Diagnostics Market Concentration Ratio
  • 3.2.1 Global STD Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by STD Diagnostics Revenue in 2019
• 3.3 STD Diagnostics Key Players Head office and Area Served
• 3.4 Key Players STD Diagnostics Product Solution and Service
• 3.5 Date of Enter into STD Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global STD Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global STD Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global STD Diagnostics Market Size by Application (2015-2020)
• 5.2 Global STD Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America STD Diagnostics Market Size (2015-2020)
• 6.2 STD Diagnostics Key Players in North America (2019-2020)
• 6.3 North America STD Diagnostics Market Size by Type (2015-2020)
• 6.4 North America STD Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe STD Diagnostics Market Size (2015-2020)
• 7.2 STD Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe STD Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe STD Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China STD Diagnostics Market Size (2015-2020)
• 8.2 STD Diagnostics Key Players in China (2019-2020)
• 8.3 China STD Diagnostics Market Size by Type (2015-2020)
• 8.4 China STD Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan STD Diagnostics Market Size (2015-2020)
• 9.2 STD Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan STD Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan STD Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia STD Diagnostics Market Size (2015-2020)
• 10.2 STD Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia STD Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia STD Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India STD Diagnostics Market Size (2015-2020)
• 11.2 STD Diagnostics Key Players in India (2019-2020)
• 11.3 India STD Diagnostics Market Size by Type (2015-2020)
• 11.4 India STD Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America STD Diagnostics Market Size (2015-2020)
• 12.2 STD Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America STD Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America STD Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott STD Diagnostics Introduction
  • 13.1.4 Abbott Revenue in STD Diagnostics Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 ADI/American Diagnostica
  • 13.2.1 ADI/American Diagnostica Company Details
  • 13.2.2 ADI/American Diagnostica Business Overview
  • 13.2.3 ADI/American Diagnostica STD Diagnostics Introduction
  • 13.2.4 ADI/American Diagnostica Revenue in STD Diagnostics Business (2015-2020)
  • 13.2.5 ADI/American Diagnostica Recent Development
• 13.3 Agilent Technologies
  • 13.3.1 Agilent Technologies Company Details
  • 13.3.2 Agilent Technologies Business Overview
  • 13.3.3 Agilent Technologies STD Diagnostics Introduction
  • 13.3.4 Agilent Technologies Revenue in STD Diagnostics Business (2015-2020)
  • 13.3.5 Agilent Technologies Recent Development
• 13.4 Alere/Biosite/Inverness
  • 13.4.1 Alere/Biosite/Inverness Company Details
  • 13.4.2 Alere/Biosite/Inverness Business Overview
  • 13.4.3 Alere/Biosite/Inverness STD Diagnostics Introduction
  • 13.4.4 Alere/Biosite/Inverness Revenue in STD Diagnostics Business (2015-2020)
  • 13.4.5 Alere/Biosite/Inverness Recent Development
• 13.5 Axis-Shield
  • 13.5.1 Axis-Shield Company Details
  • 13.5.2 Axis-Shield Business Overview
  • 13.5.3 Axis-Shield STD Diagnostics Introduction
  • 13.5.4 Axis-Shield Revenue in STD Diagnostics Business (2015-2020)
  • 13.5.5 Axis-Shield Recent Development
• 13.6 Beckman Coulter/Danaher
  • 13.6.1 Beckman Coulter/Danaher Company Details
  • 13.6.2 Beckman Coulter/Danaher Business Overview
  • 13.6.3 Beckman Coulter/Danaher STD Diagnostics Introduction
  • 13.6.4 Beckman Coulter/Danaher Revenue in STD Diagnostics Business (2015-2020)
  • 13.6.5 Beckman Coulter/Danaher Recent Development
• 13.7 Becton Dickinson
  • 13.7.1 Becton Dickinson Company Details
  • 13.7.2 Becton Dickinson Business Overview
  • 13.7.3 Becton Dickinson STD Diagnostics Introduction
  • 13.7.4 Becton Dickinson Revenue in STD Diagnostics Business (2015-2020)
  • 13.7.5 Becton Dickinson Recent Development
• 13.8 Bio/Data
  • 13.8.1 Bio/Data Company Details
  • 13.8.2 Bio/Data Business Overview
  • 13.8.3 Bio/Data STD Diagnostics Introduction
  • 13.8.4 Bio/Data Revenue in STD Diagnostics Business (2015-2020)
  • 13.8.5 Bio/Data Recent Development
• 13.9 Decode Genetics
  • 13.9.1 Decode Genetics Company Details
  • 13.9.2 Decode Genetics Business Overview
  • 13.9.3 Decode Genetics STD Diagnostics Introduction
  • 13.9.4 Decode Genetics Revenue in STD Diagnostics Business (2015-2020)
  • 13.9.5 Decode Genetics Recent Development
• 13.10 Diadexus
  • 13.10.1 Diadexus Company Details
  • 13.10.2 Diadexus Business Overview
  • 13.10.3 Diadexus STD Diagnostics Introduction
  • 13.10.4 Diadexus Revenue in STD Diagnostics Business (2015-2020)
  • 13.10.5 Diadexus Recent Development
• 13.11 Diagnocure
  • 10.11.1 Diagnocure Company Details
  • 10.11.2 Diagnocure Business Overview
  • 10.11.3 Diagnocure STD Diagnostics Introduction
  • 10.11.4 Diagnocure Revenue in STD Diagnostics Business (2015-2020)
  • 10.11.5 Diagnocure Recent Development
• 13.12 Diagnostica Stago/Trinity Biotech
  • 10.12.1 Diagnostica Stago/Trinity Biotech Company Details
  • 10.12.2 Diagnostica Stago/Trinity Biotech Business Overview
  • 10.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Introduction
  • 10.12.4 Diagnostica Stago/Trinity Biotech Revenue in STD Diagnostics Business (2015-2020)
  • 10.12.5 Diagnostica Stago/Trinity Biotech Recent Development
• 13.13 Diamedix
  • 10.13.1 Diamedix Company Details
  • 10.13.2 Diamedix Business Overview
  • 10.13.3 Diamedix STD Diagnostics Introduction
  • 10.13.4 Diamedix Revenue in STD Diagnostics Business (2015-2020)
  • 10.13.5 Diamedix Recent Development
• 13.14 Polymedco
  • 10.14.1 Polymedco Company Details
  • 10.14.2 Polymedco Business Overview
  • 10.14.3 Polymedco STD Diagnostics Introduction
  • 10.14.4 Polymedco Revenue in STD Diagnostics Business (2015-2020)
  • 10.14.5 Polymedco Recent Development
• 13.15 Qiagen
  • 10.15.1 Qiagen Company Details
  • 10.15.2 Qiagen Business Overview
  • 10.15.3 Qiagen STD Diagnostics Introduction
  • 10.15.4 Qiagen Revenue in STD Diagnostics Business (2015-2020)
  • 10.15.5 Qiagen Recent Development
• 13.16 Roche
  • 10.16.1 Roche Company Details
  • 10.16.2 Roche Business Overview
  • 10.16.3 Roche STD Diagnostics Introduction
  • 10.16.4 Roche Revenue in STD Diagnostics Business (2015-2020)
  • 10.16.5 Roche Recent Development
• 13.17 SDIX
  • 10.17.1 SDIX Company Details
  • 10.17.2 SDIX Business Overview
  • 10.17.3 SDIX STD Diagnostics Introduction
  • 10.17.4 SDIX Revenue in STD Diagnostics Business (2015-2020)
  • 10.17.5 SDIX Recent Development
• 13.18 Sequenom
  • 10.18.1 Sequenom Company Details
  • 10.18.2 Sequenom Business Overview
  • 10.18.3 Sequenom STD Diagnostics Introduction
  • 10.18.4 Sequenom Revenue in STD Diagnostics Business (2015-2020)
  • 10.18.5 Sequenom Recent Development
• 13.19 Siemens
  • 10.19.1 Siemens Company Details
  • 10.19.2 Siemens Business Overview
  • 10.19.3 Siemens STD Diagnostics Introduction
  • 10.19.4 Siemens Revenue in STD Diagnostics Business (2015-2020)
  • 10.19.5 Siemens Recent Development
• 13.20 Sienco
  • 10.20.1 Sienco Company Details
  • 10.20.2 Sienco Business Overview
  • 10.20.3 Sienco STD Diagnostics Introduction
  • 10.20.4 Sienco Revenue in STD Diagnostics Business (2015-2020)
  • 10.20.5 Sienco Recent Development
• 13.21 Sysmex
  • 10.21.1 Sysmex Company Details
  • 10.21.2 Sysmex Business Overview
  • 10.21.3 Sysmex STD Diagnostics Introduction
  • 10.21.4 Sysmex Revenue in STD Diagnostics Business (2015-2020)
  • 10.21.5 Sysmex Recent Development
• 13.22 Takara Bio
  • 10.22.1 Takara Bio Company Details
  • 10.22.2 Takara Bio Business Overview
  • 10.22.3 Takara Bio STD Diagnostics Introduction
  • 10.22.4 Takara Bio Revenue in STD Diagnostics Business (2015-2020)
  • 10.22.5 Takara Bio Recent Development
• 13.23 ThermoFisher
  • 10.23.1 ThermoFisher Company Details
  • 10.23.2 ThermoFisher Business Overview
  • 10.23.3 ThermoFisher STD Diagnostics Introduction
  • 10.23.4 ThermoFisher Revenue in STD Diagnostics Business (2015-2020)
  • 10.23.5 ThermoFisher Recent Development
• 13.24 Tosoh
  • 10.24.1 Tosoh Company Details
  • 10.24.2 Tosoh Business Overview
  • 10.24.3 Tosoh STD Diagnostics Introduction
  • 10.24.4 Tosoh Revenue in STD Diagnostics Business (2015-2020)
  • 10.24.5 Tosoh Recent Development
• 13.25 Wako
  • 10.25.1 Wako Company Details
  • 10.25.2 Wako Business Overview
  • 10.25.3 Wako STD Diagnostics Introduction
  • 10.25.4 Wako Revenue in STD Diagnostics Business (2015-2020)
  • 10.25.5 Wako Recent Development
• 13.26 Zycare/Alere
  • 10.26.1 Zycare/Alere Company Details
  • 10.26.2 Zycare/Alere Business Overview
  • 10.26.3 Zycare/Alere STD Diagnostics Introduction
  • 10.26.4 Zycare/Alere Revenue in STD Diagnostics Business (2015-2020)
  • 10.26.5 Zycare/Alere Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer